Twitter

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

Condition:   Hormone Refractory Prostate Cancer
Intervention:   Drug: Cabazitaxel 10 mg/m2
Sponsor:   Spanish Oncology Genito-Urinary Group
Not yet recruiting – verified January 2012

Read more: Study of Weekly Cabazitaxel for Advanced Prostate Cancer




Comments are closed.